Previous close | 2.2500 |
Open | 2.2700 |
Bid | 2.3300 x 100 |
Ask | 2.4400 x 100 |
Day's range | 2.2700 - 2.4700 |
52-week range | 1.9780 - 4.2950 |
Volume | |
Avg. volume | 102,291 |
Market cap | 110.844M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.3000 |
Earnings date | 06 Mar 2024 - 11 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.70 |
Discover how KORU Medical Systems achieved its highest quarterly revenue and is strategically positioning for future growth.
Insightful Analysis on KORU Medical's Financial Performance and Strategic Directions
MAHWAH, N.J., May 01, 2024--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the first quarter ended March 31, 2024.